Sebastian Ewen

Showing 1-11 of 11 articles

Bare metal or drug-eluting stent versus drug-coated balloon in non-ST-elevation myocardial infarction: the randomised PEPCAD NSTEMI trial

Scheller B, Ohlow M, Ewen S, Kische S, Rudolph T, Clever Y, Wagner A, Richter S, El-Garhy M, Böhm M, Degenhardt R, Mahfoud F, Lauer B

April 17, 2020 | 10.4244/EIJ-D-19-00723

Will SPYRAL HTN-ON MED change my practice? SPYRAL HTN-ON MED: a prospective, randomised, sham-controlled trial on renal denervation in the presence of antihypertensive medications

Ewen S, Lauder L, Azizi M, Kandzari D, Pathak A, Sharif F, Wijns W, Mahfoud F, Lüscher T

August 3, 2018 | 10.4244/EIJY18M07_1

Will SPYRAL HTN-OFF MED change my practice? SPYRAL HTN-OFF MED: a prospective, randomised, sham-controlled trial on renal denervation in the absence of antihypertensive medications

Lauder L, Ewen S, Azizi M, Mauri L, Lurz P, Lobo M, Sharif F, Wijns W, Tsioufis C, Mahfoud F

August 3, 2018 | 10.4244/EIJY18M07_2

Other

Renal artery anatomy assessed by quantitative analysis of selective renal angiography in 1,000 patients with hypertension

Lauder L, Ewen S, Tzafriri A, Edelman E, Lüscher T, Blankestijn P, Dörr O, Schlaich M, Sharif F, Voskuil M, Zeller T, Ukena C, Scheller B, Böhm M, Mahfoud F

May 20, 2018 | 10.4244/EIJ-D-18-00112

Interventions for hypertension

Will SPRINT change my practice? SPRINT: a randomised trial of intensive versus standard blood-pressure control

Ewen S, Lobo M, Pathak A, Schmieder R, Tsioufis C, Wijns W, Mahfoud F

August 20, 2016 | 10.4244/EIJV12I6A132

Renal sympathetic nerve denervation using intraluminal ultrasound within a cooling balloon preserves the arterial wall and reduces sympathetic nerve activity

Pathak A, Coleman L, Roth A, Stanley J, Bailey L, Markham P, Ewen S, Morel C, Despas F, Honton B, Senard J, Fajadet J, Mahfoud F

August 20, 2015 | 10.4244/EIJV11I4A96

From SYMPLICITY HTN-3 to the Renal Denervation Global Registry: where do we stand and where should we go?

Pathak A, Ewen S, Fajadet J, Honton B, Mahfoud F, Marco J, Schlaich M, Schmieder R, Tsioufis C, Ukena C, Zeller T

May 20, 2014 | 10.4244/EIJV10I1A4

Response and non-response to renal denervation: who is the ideal candidate?

Ukena C, Cremers B, Ewen S, Böhm M, Mahfoud F

May 21, 2013 | 10.4244/EIJV9SRA10

Expanding the indication spectrum: renal denervation in diabetes

Mahfoud F, Ewen S, Ukena C, Linz D, Sobotka P, Cremers B, Böhm M

May 21, 2013 | 10.4244/EIJV9SRA20

Therapeutic potential of renal sympathetic denervation in patients with chronic heart failure

Böhm M, Ewen S, Linz D, Reil J-C, Schirmer S, Ukena C, Mahfoud F

May 21, 2013 | 10.4244/EIJV9SRA21

First-in-human experience: percutaneous renal denervation through a false lumen fenestration in aortic dissection type B

Ewen S, Mahfoud F, Böhm M

January 18, 2013 | 10.4244/EIJV8I9A170

Latest news

NEW ISSUE

Focus on emerging physiology indices, TAVI, sizing with abnormal aortic cusps, a megaregistry of complex PCIs and more…

Hinge point-based aortic annular plane

September 18, 2020

NEW

Ahead of print: Histopathology of embolic debris during TAVI

September 18, 2020

Editorial

Transcatheter VIV implantation for failed surgical bioprostheses

J. Mehilli

September 18, 2020

PCR Trials

VOYAGER PAD, PARTNER 2A, ISCHEMIA and much more

(The Trials book is supported by Biotronik)

August 28, 2020

Twitter

Over 10,000 followers

Thank you!

September 18, 2020

Editorial

Steady-state hyperaemia: many routes, one goal

G.G. Toth

September 18, 2020

JAA

This Week's JAA's: Leaflex study, Coronary access after REDO-TAVI...